/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Risks and benefits of antiplatelet therapy in patients with abdominal aortic aneurysm without symptomatic atherosclerotic disease: a nationwide cohort study
Event: ESC Congress 2023
Topic: Pharmacotherapy
Session: The thoracoabdominal aorta in the spotlight: aneurysms, dissections, and their prognosis
Changes in antithrombotic treatment in patients with abdominal aortic aneurysmal disease and incident atrial fibrillation: a population-based case-crossover analyses
Event: ESC Congress 2021 - The Digital Experience
Topic: Pharmacotherapy
Session: Diseases of the Aorta ePosters
ESC 365 is supported by
